← All indications
Eczema
A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents.
Subtype terms (1)
More specific conditions that are subtypes of Eczema in the MeSH hierarchy.
- Eczema, Dyshidrotic
1 drug experimental
Drugs by status
Approved for this indication (11)
Phase 4 trials (12)
Phase 3 trials (35)
- vitamin d3
- benzocaine
- bacille calmette-guerin
- cetirizine
- clobetasol
- oatmeal
- diphenhydramine
- epiceram
- fusidic acid
- icosapent ethyl
- lebrikizumab
- pf-04965842
- roseomonas
- ruxolitinib
- levobupivacaine
- cyclosporine
- tralokinumab
- levocetirizine
- ecologic
- fentanyl
- gentamicin
- amino acids
- desloratadine
- fluocinolone acetonide
- azathioprine
- pseudoephedrine
- tolnaftate
- dropropizine
- polymyxin b sulfate
- lactobacillus casei
- +5 more
Phase 2 trials (48)
- maltodextrin
- fluticasone
- alclometasone
- b244
- benralizumab
- apremilast
- tofacitinib
- doxycycline
- prednicarbate
- nifedipine
- cannabidiol
- ganoderma lucidum spore
- ltx-109
- tradipitant
- metal allergen
- boric acid
- nanocrystalline silver
- octenidine
- peanut
- san007
- benzyl alcohol
- mapracorat
- alx-101
- autologous microbiome
- ky1005
- autologous skin microbiome
- zl-3101
- zinc dichloride
- leo80122
- furoic acid
- +18 more
Phase 1 trials (10)
Other trials (26)
- act01
- petrolatum, white
- canola oil
- pimecrolimus
- glycerin
- cyanocobalamin
- aluminum hydroxide
- propylene glycol
- sunflower oil
- acetic acid
- p-aminobenzoic acid
- hydrolyzed casein
- palmityl alcohol
- octocrylene
- shea butter
- mullberry
- alitretinoin
- sodium monododecyl sulfate
- omega-3 fatty acids
- coal tar
- lactobacillus rhamnosus
- 2-mercaptobenzothiazole
- mineral oil
- nickel sulfate hexahydrate
- cls02021
- isopropyl myristate
Organizations
Organization Involved with Phase 4 Indications (64)
- Fougera
- Regeneron
- Medicis
- Astellas
- Perrigo
- Pfizer
- Sanofi
- Novartis
- Ceragenix Pharmaceuticals
- Ferndale Laboratories, Inc.
- GlaxoSmithKline
- Tongjitang Pharmaceutical Co.,Ltd
- Max Zeller Soehne AG
- Derm Research, PLLC
- Casa Espirita Terra de Ismael
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institute of Allergy and Infectious Diseases (NIAID)
- Mead Johnson
- Emer, Jason, M.D.
- University of Pennsylvania
- University of London
- Children´s Clinic, Randers
- Harvard University
- Hoosier Cancer Research Network
- Northwestern University
- Oregon Health and Science University
- Radboud University
- St. Luke's-Roosevelt Hospital Center
- Stanford University
- Thomas Jefferson University
- +34 more
Organization Involved with Phase 3 Indications (64)
- Pierre Fabre
- Galderma
- Incyte
- AbbVie
- Actavis
- DPT Laboratories
- Meda
- Basilea Pharmaceutica
- Bausch Health Companies
- Stiefel Laboratories
- Eli Lilly
- Mylan
- Amorepacific Corporation
- Avva Rus, JSC
- Endo Pharmaceuticals
- Kang Stem Biotech Co., Ltd.
- Merz
- Moberg Pharma AB
- NeoStrata Company, Inc.
- Par Pharmaceuticals
- Salvat
- Vifor Inc.
- Agentschap NL
- Dermira, Inc.
- Otsuka
- ZonMw: The Netherlands Organisation for Health Research and Development
- Medical Research Council
- National Hepatology & Tropical Medicine Research Institute
- Chang Gung University
- Chungbuk National University
- +34 more
Organization Involved with Phase 2 Indications (166)
- Aclaris Therapeutics, Inc.
- Daiichi Sankyo
- PreCision Dermatology
- Eisai
- UCB
- Celgene
- Galapagos NV
- Amgen
- Roche
- AstraZeneca
- Genentech
- MedImmune
- Shionogi
- AOBiome LLC
- Allerderm
- Almirall
- Aerovance, Inc.
- AnaMar AB
- AnaptysBio, Inc.
- Anesiva, Inc.
- Arena Pharmaceuticals
- Aria Aesthetics Inc.
- Union Therapeutics
- Asana BioSciences
- Atopix Therapeutics, Ltd.
- Bavarian Nordic
- Bellus Health Inc
- BioCis Pharma Ltd
- BioMAS Ltd
- Celsion
- +136 more
Organization Involved with Phase 1 Indications (16)
- Bristol-Myers Squibb
- Novan, Inc.
- Parexel
- Aslan Pharmaceuticals
- Makati Medical Center
- University of Nebraska
- Xencor
- Proinnovera GmbH
- Pharmaceutical Research Associates, Inc. (PRA)
- Medicines Evaluation Unit Ltd
- J. W. Goethe University
- Weizmann Institute of Science
- Atopic Dermatitis and Vaccinia Network
- Evelo Biosciences
- University of Surrey
- RAPT Therepeutics, Inc.
Organization Involved with Other Experimental Indications (42)
- Applied Biology, Inc.
- BioGaia AB
- Cosmetique Active International
- Heinz
- Teikoku Pharma USA, Inc.
- GenMont Biotech Incorporation
- Swiss National Science Foundation
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Noos S.r.l.
- Aarhus University
- University of Arizona
- Cairo University
- Institut National de la Santé Et de la Recherche Médicale, France
- McMaster University
- Medical College of Wisconsin
- Ostergotland County Council, Sweden
- Pontificia Universidad Catolica de Chile
- Spartanburg Regional Family Medicine
- Srinakharinwirot University
- University of Hamburg
- University of Southern Denmark
- University of Bonn
- University of California, Los Angeles
- University of Naples Frederico II
- Clinica Pediatrica Ospedale dei Bambini Vittore Buzzi
- University of Western Brittany
- Friedrich Schiller University
- TKL Research
- Soonchunhyang University
- University of Nantes
- +12 more